BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $5.8 million versus the consensus estimate of $5.92 million.

GUIDANCE:

BioLife Solutions sees FY2019 revenue of $27-30 million, versus the consensus of $28.7 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.